comparemela.com
Home
Live Updates
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update : comparemela.com
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
NDA submitted to US FDA for ensifentrine for maintenance treatment of COPD Phase 3 ENHANCE data published in the American Journal of Respiratory and Critical Care Medicine Strong balance sheet to...
Related Keywords
United Kingdom ,
London ,
City Of ,
United States ,
Ukraine ,
American ,
Verona Pharma ,
Leslie Humbel ,
David Zaccardelli ,
Drug Administration ,
European Respiratory Society International Congress ,
Bridge Communications ,
International Us Media Enquiries ,
American Thoracic Society International Conference ,
Globenewswire Inc ,
Program Updates ,
Nasdaq ,
Critical Care ,
New Drug Application ,
Chief Executive ,
Critical Care Medicine ,
Respiratory Society International Congress ,
Thoracic Society International Conference ,
Kingdom Tel ,
Senior Director ,
Investor Relations ,
Annual Report ,
Quarterly Reports ,
comparemela.com © 2020. All Rights Reserved.